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Abstract Regulation by vitamin D3 of expression of the genes
for stanniocalcins 1 and 2 (STC-1 and STC-2) was studied and
their levels were shown to be oppositely regulated in the kidney
and to remain unaffected in the ovary. Female rats were treated
with calcitriol, the active form of vitamin D3, and alterations in
the levels of STC-1 and STC-2 mRNA were determined by
Northern blot analysis in the kidney and ovary where the STC-1-
expressing cells have previously been identified by in situ
hybridization histochemistry. In the kidney, calcitriol treatment
increased the STC-1 mRNA levels more than 3-fold, but
decreased the STC-2 message to trace levels. In the ovary,
however, both STC-1 and STC-2 mRNA levels were not
significantly affected by the calcitriol treatment. These results
support the hypotheses that (1) STC-1 and STC-2 have opposite
effects on calcium and phosphate homeostasis, namely anti-
hypercalcemic and anti-hypocalcemic actions, respectively, and
(2) the mammalian stanniocalcin system acquired, in addition to
the role in the systemic mineral metabolism, a role in the
reproduction system that operates independently of the systemic
condition.
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1. Introduction
Stanniocalcins are a group of glycoprotein hormones that
are involved in the maintenance of calcium and phosphate
homeostasis [1]. Stanniocalcin was ¢rst (1) identi¢ed as a di-
sul¢de-linked homodimeric hormone secreted from the cor-
puscles of Stannius, endocrine glands associated with the kid-
neys of the bony ¢shes, (2) shown to prevent hypercalcemia
by reducing Ca2 in£ux from the gill, by promoting renal
reabsorption of phosphate which chelates excess Ca2 and
stimulates its deposition to bones and scales, and by inhibiting
Ca2 uptake from the intestine, and (3) considered to be a
regulator unique to ¢shes for a long time until the discovery
of its mammalian counterparts, human [2,3] and mouse [4]
stanniocalcin. The mammalian stanniocalcin is similar to the
¢sh hormone in its amino acid sequence and anti-hypercalce-
mic actions but exhibits quite di¡erent tissue distribution; in
mammals, stanniocalcin occurs in a wide variety of tissues
including the kidney, brain, heart, lung, bone, and ovary [2^
13].
Recently, a related protein of V300 amino acid residues
was cloned by three groups [14^16] based on the sequence
information (AA497118, AA195455, AA298636, AA456244,
AA497040, AA223369, AA423593) in the EST database
dbEST and named stanniocalcin 2 (STC-2) [14,16] or stannio-
calcin-related protein (STCrP) [15]. In the case of the STC-2
nomenclature, stanniocalcin was renamed stanniocalcin 1
(STC-1). Although STC-1 and STC-2 share a moderate se-
quence similarity (V40%) in their N-terminal region, they
are quite divergent in the C-terminal region. Furthermore,
STC-1 and STC-2 have been suggested to exert opposite ef-
fects on the phosphate uptake mediated by the Na/phos-
phate cotransporter 3 [16].
In contrast to the detailed characterization of the biochem-
ical and physiological properties of stanniocalcins, their regu-
lation of expression is poorly understood. While the mode of
regulation of expression of the ¢sh stanniocalcin gene in the
corpuscles of Stannius has been studied to some extent [17],
that of the mammalian genes for STC-1 and STC-2 remains
poorly characterized. We report here the e¡ects of 1K,25-di-
hydroxyvitamin D3 (calcitriol, the hormonal form of vitamin
D) on the levels of stanniocalcin mRNA in the rat kidney and
ovary.
2. Materials and methods
2.1. Animal treatment
Female Sprague-Dawley rats (6 weeks old) were obtained from the
Tokyo Laboratory Animals Co. and housed 2^3 per cage, given food
and water ad libitum, and maintained on a normal 12-h light/dark
cycle. Calcitriol (1 Wg/kg/day) or saline was injected intraperitoneally
for 2 and 6 days, 1 h before the dark cycle. At the end of the exper-
imental period, animals were killed by decapitation, and the kidneys
and ovaries were removed, immediately frozen in liquid nitrogen, and
stored at 380‡C until use.
2.2. Preparation of cDNA probes
To obtain STC-1 and STC-2 cDNA probes, we ¢rst ampli¢ed by
PCR a part of the human STC-1 and rat STC-2 sequence covering the
coding region, using human and rat kidney cDNA as templates, which
was performed using ExTaq (Takara) DNA polymerase and the fol-
lowing oligonucleotide primers: 5P-TGTGAATAACCTCTCCCTGG-
3P (STC-1, antisense), 5P-TAGCGGAAACTTCTCAGAGA-3P (STC-
1, sense), 5P-CTTTCATTTCACCTCCGGAT-3P (STC-2, antisense)
and 5P-ATACCAAGAACCATGTGTGC-3P (STC-2, sense). The
PCR was run for 35 cycles by repeating denaturation at 94‡C for
30 s, annealing at 60‡C for 1 min and polymerization at 72‡C for
2 min. Products of expected sizes were isolated by agarose gel electro-
phoresis, puri¢ed, and then subcloned into the EcoRV site of pBlue-
script and sequenced. The novel rat STC-2 sequence covering all the
coding region has been submitted to the DDBJ/GenBank/EMBL
Data Bank with accession number AB030707. Rat STC-2 consists
of 296 amino acid residues and shares V96% amino acid sequence
identity with mouse STC-2 (296 amino acid residues) and V84%
identity with human STC-2 (302 amino acid residues). Our original
intention in isolating human STC-1 cDNA was to raise monospeci¢c
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antisera against the recombinant protein, but here we used it for
quanti¢cation of rat STC-1 mRNA since it is highly homologous to
the rat sequence (V92%).
2.3. Total RNA isolation and Northern blot analysis
Total RNA was isolated by the acid guanidinium thiocyanate/phe-
nol/chloroform method. For Northern analysis, 20 Wg of total RNA
was electrophoresed in 1% agarose gel containing formaldehyde and
transferred to Magna MT nylon membrane (Micron Separation) by
capillary blotting overnight using 20USSC (SSC: 0.15 M NaCl, 15
mM sodium citrate, pH 7.0) as the transfer bu¡er. After transfer,
membranes were baked for 2 h at 80‡C and prehybridized for 30
min at 37‡C in 5USSPE (SSPE: 0.15 M NaCl, 1 mM EDTA, and
10 mM NaH2PO4, pH 7.4) containing 50% formaldehyde, 5UDen-
hardt’s solution (Denhardt’s : 0.1% each of Ficoll, polyvinylpyrroli-
done, and bovine serum albumin), and 0.5% SDS. The above PCR-
derived human STC-1 and rat STC-2 cDNA was labeled with [K-
32P]dCTP (3000 Ci/mmol, Amersham Pharmacia Biotech) using a
Ready-To-Go DNA labeling kit (Amersham Pharmacia Biotech),
and the unincorporated nucleotides were removed by passage through
a Sephadex G-50 column (Amersham Pharmacia Biotech). Hybrid-
ization was performed at 42‡C for 16 h. After hybridization, the
membranes were rinsed twice with 2USSC and 0.1% SDS for 30
min at 50‡C, washed with 1USSC and 0.1% SDS for 30 min at
55‡C and twice with 0.5USSC and 0.1% SDS for 1 h at 55‡C, and
exposed to imaging plates (Fuji Film) in a cassette for 1 week. The
results were analyzed using a Fujix BAS2000 Bio-imaging analyzer
(Fuji Film).
3. Results
3.1. Veri¢cation of calcitriol treatment
The e¡ectiveness of the calcitriol treatment was veri¢ed by
measuring the plasma levels of Ca2. Following the treatment,
plasma concentration of Ca2 was increased from 2.47 þ 0.16
mM (n = 4) to 3.13 þ 0.19 (n = 5, day 2) and 3.10 þ 0.18 mM
(n = 5, day 6), demonstrating the well established hypercalce-
mic e¡ect of calcitriol.
3.2. Up-regulation of STC-1 and down-regulation of STC-2
gene expressions in the rat kidney on calcitriol treatment
For Northern blot analyses, we chose the kidney and ovary
as the sources of mRNA since they have been demonstrated
to contain relatively high levels of stanniocalcin mRNA and
furthermore they are so far the only mammalian tissues in
which the sites of STC-1 expression have been clari¢ed at
the cellular level by autoradiographic in situ hybridization
histochemistry: the cortical and medullary collecting duct cells
of the kidney [11] and the secondary interstitial cells and the-
ca-interna cells of the ovary [12] have been established as the
major sites of STC-1 mRNA expression. As shown in Fig. 1,
the STC-1 message levels in the kidney increased about 3-fold
on calcitriol treatment (lanes 5 and 6 compared with lane 4).
In marked contrast, STC-2 mRNA expression was reduced to
about 20% of the level found before calcitriol treatment (Fig.
2, lanes 5 and 6 compared with lane 4). This tendency is
somewhat surprising but consistent with the recent observa-
tion by Ishibashi et al. [16] that the e¡ect of STC-2 on the
Na/phosphate cotransporter 3 was opposite to that of STC-1
and strongly suggests that although STC-1 and STC-2 belong
to the same stanniocalcin family, they act as anti-hypercalce-
mic and anti-hypocalcemic agents, respectively, to restore nor-
mocalcemia. Together with previous reports from other labo-
ratories describing modulations by STC-1 of renal phosphate
excretion [3,18] and of intestinal Ca2 and phosphate uptake
[19], the calcitriol sensitivity of STC-1 and STC-2 expression,
demonstrated here in the mammalian system for the ¢rst time,
indicates that the mammalian stanniocalcin system also plays
important roles in maintaining systemic calcium and phos-
phate homeostasis by working in harmony with other calci-
um-mobilizing hormones.
3.3. Stanniocalcin levels in the rat ovary are regulated
independently of the systemic calcium levels
Using the mouse, Varghese et al. [12] have shown that the
ovary contains the highest levels of STC-1 mRNA. We there-
fore determined STC-1 and STC-2 message levels in the ovary
of calcitriol-treated rats by Northern blot analysis (lanes 1^3
in Figs. 1 and 2). Our results indicated that the STC-2 gene
was also highly expressed in the ovary but neither STC-1 nor
STC-2 mRNA levels were signi¢cantly altered by the treat-
ment, suggesting that the ovary has an autocrine/paracrine
stanniocalcin system working independently of the calcium
levels in the systemic circulation. The function of the ovarian
stanniocalcins, for example whether they are involved in the
maintenance of Ca2 and phosphate homeostasis within the
ovary or whether they gained a completely di¡erent reproduc-
tive role during evolution of the mammalian species, remains
to be clari¢ed.
Fig. 1. Northern blot analysis of STC-1 mRNA in the ovary (A)
and kidney (B) of the control and calcitriol-treated rats. Upper pan-
els : STC-1 mRNA levels probed with 32P-labeled STC-1 cDNA.
Middle panels: loading controls showing the levels of L-actin
mRNA. Total RNA was prepared from the tissues on day 0 (lanes
1 and 4), 2 (lanes 2 and 5), and 6 (lanes 3 and 6) after calcitriol
treatment. Each lane contains 20 Wg of total RNA preparations.
Lower panels: densitometric analysis. Quantitation was performed
by measuring the photostimulated luminescence (PSL) values using
a Fuji Film bioimage analyzer (Model 2000) and by comparing
STC-1 transcript levels with those of L-actin. The ratio of STC-1
transcript to L-actin at day 0 was set at 1 (n = 3).
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4. Discussion
In the present study, we determined the e¡ects of calcitriol
on the message levels of STC-1 and STC-2 in the rat kidney
and ovary. The major ¢ndings are as follows. (1) STC-1
mRNA levels were increased in the kidney of calcitriol-treated
rats; this is consistent with the anti-hypercalcemic nature of
STC-1. (2) In the case of STC-2, however, a marked reduction
occurred. (3) In the ovary, both STC-1 and STC-2 mRNA
levels remained una¡ected by the treatment, suggesting the
presence of an independently operating ovarian stanniocalcin
system. Of special interest is the second ¢nding, which sup-
ports the recent communication by Ishibashi et al. [16] report-
ing an inhibitory e¡ect of STC-2 on the Na/phosphate co-
transporter activity (cf. STC-1 is a stimulator of the
transporter) and strongly suggests that STC-1 and STC-2
are counteracting molecules, STC-1 being anti-hypercalcemic
and STC-2 anti-hypocalcemic. In this context, structural fea-
tures unique to STC-2 may deserve comment: Chang and
Reddel [14] have noted the presence of a cluster of histidine
residues (HHxxxxHH) in its C-terminal portion and pointed
out its potential for interaction with metal ions; and Hulova
and Kawauchi [20] have shown that although all 10 cysteine
residues involved in intramolecular disul¢de bonds are com-
pletely conserved, including their spacings, among the stan-
niocalcin molecules so far sequenced, the position of the 11th
cysteine residue that is responsible for the disul¢de-linked ho-
modimer formation is not spatially conserved between STC-1
and STC-2.
Calcitriol has been established to be hypercalcemic and
there are several reports that suggest that increased Ca2 lev-
els stimulate the STC-1 gene expression or stabilize the STC-1
message. For example, Chang et al. [2] have demonstrated
using a human cell line that the STC-1 mRNA levels are
positively regulated by Ca2 in the medium; Srivastav et al.
[21] have shown that plasma Ca2 and stanniocalcin levels in
tilapia are increased by calcitriol treatment; Sato et al. [7]
have identi¢ed stanniocalcin as a protein whose mRNA is
strongly inducible in vascular endothelial cells treated with
lysophosphatidylcholine which is known to increase Ca2 in-
£ux [22] ; and Ellis and Wagner [23] have demonstrated using
primary culture of trout corpuscles of Stannius cells that STC-
1 mRNA is stabilized by Ca2. It is therefore likely that the
above mentioned e¡ects of calcitriol on the STC-1 and STC-2
mRNA levels are mediated through Ca2. Whether the regu-
lations occur at the level of transcription or, like the ¢sh
corpuscles of Stannius [23], at the level of post-transcription
or both remains to be determined.
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